CMPX earnings: a negative outcome, -17.6%

On April 30, 2021, Compass Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -17.6% in the window around the event. It had already run +54.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.